Lab study explores how JAK inhibitors affect immune cells in arthritis
NCT ID NCT03755297
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how JAK-STAT inhibitors, a type of drug used for rheumatoid arthritis, affect certain immune cells called regulatory B cells. Researchers analyzed blood samples from 27 patients to see if these drugs could boost anti-inflammatory functions. The study was terminated early, so findings are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- JAK-STAT inhibitors (tested in blood samples in the lab)
- What this could lead to
- If successful, this could point toward a better understanding of how JAK inhibitors work in rheumatoid arthritis, potentially leading to improved treatments.
- What could go wrong
- This was a small, early-stage lab study that was terminated, so results are limited. It does not test a new drug directly in patients, so any benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of Montpellier
Montpellier, 34, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can discarded bone reveal the secrets to stronger bones?
- Can a new shoulder implant restore Pain-Free movement?
- Can a less invasive hip surgery speed up recovery?
- Which hip implant lasts longer? a Head-to-Head trial aims to find out
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers
- Ear cartilage to the rescue? a tiny biopsy could rebuild knees